Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry
Giulia Rastrelli(University of Florence), Mario Maggi(University of Florence), Alessandra Sperandio(University of L'Aquila), Riccardo Selice(University of Padua), Vito Angelo Giagulli(University of Bari Aldo Moro), Francesco Cocchiara(University of Genoa), Daniele Gianfrilli(Sapienza University of Rome), Aldo E. Calogero(University of Catania), G. Vancieri(University of Rome Tor Vergata), Emmanuele Serra(University of Cagliari), Giovanni Luca(University of Perugia), Giovanna Motta(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Lara Giovannini(Marche Polytechnic University), Domenico Canale(University of Pisa), Sebastiano Andò(University of Calabria), Alessandro Pizzocaro(Humanitas University)
Cited by 17
Related Papers
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study
|European Journal of Endocrinology|2011|434
US-Elastography in the Differential Diagnosis of Benign and Malignant Thyroid Nodules
|Thyroid|2008|417
Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis
|European Journal of Endocrinology|2013|406
Testosterone and Metabolic Syndrome: A Meta-Analysis Study
|The Journal of Sexual Medicine|2010|395
Type 2 diabetes mellitus and testosterone: a meta-analysis study
|International Journal of Andrology|2010|369